Traditional MedicareCoverageMedium impact
Important information regarding Medicare GLP-1 Bridge through CMS
UPMC Health Plan·Bariatric Surgery, Endocrinology, Family Medicine +2 more·Provider Announcement
Effective date
Jul 1, 2026
We identified it
Jun 26, 2026
Summary
CMS is launching the Medicare GLP-1 Bridge, a short-term demonstration program starting July 1, 2026, that provides GLP-1 medications to eligible Medicare Part D beneficiaries for weight management outside standard Part D coverage. The program uses a central processor for prior authorization, claims processing, and pharmacy payment. Billing teams must understand eligibility criteria and coordinate with this new pathway for GLP-1 claims.
Action Required
By June 30, 2026: Billing team must review CMS GLP-1 Bridge program details at cms.gov/files/document/glp-1-prescribers-c-1.pdf and establish processes to identify eligible Medicare Part D beneficiaries for this program. Providers must verify that patients meet eligibility criteria (no Type 2 diabetes, no moderate-to-severe OSA, no MASH, not eligible through Part D plan). Billing staff should update claim submission workflows to route GLP-1 claims through the central processor when applicable. Train front-desk and clinical staff to screen patients during intake to determine eligibility for the bridge program versus traditional Part D coverage. Establish communication protocol with pharmacy partners regarding the central processor pathway. Failure to route claims correctly may result in denials or payment delays.